These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition. Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565 [TBL] [Abstract][Full Text] [Related]
26. The fate of an endothelium layer after preconditioning. Yazdani SK; Tillman BW; Berry JL; Soker S; Geary RL J Vasc Surg; 2010 Jan; 51(1):174-83. PubMed ID: 20117500 [TBL] [Abstract][Full Text] [Related]
27. Short-term patency of 1 mm diameter PTFE prosthesis: an angiographic, Doppler-flowmetric and morphological experimental study. Durante CM; Camboni A; Bianchi S; Macchiarelli G Ital J Anat Embryol; 2005; 110(2 Suppl 1):117-25. PubMed ID: 16101029 [TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinase inhibition reduces intimal hyperplasia in a porcine arteriovenous-graft model. Rotmans JI; Velema E; Verhagen HJ; Blankensteijn JD; de Kleijn DP; Stroes ES; Pasterkamp G J Vasc Surg; 2004 Feb; 39(2):432-9. PubMed ID: 14743149 [TBL] [Abstract][Full Text] [Related]
29. Microvascular endothelial cell sodding of ePTFE vascular grafts: improved patency and stability of the cellular lining. Williams SK; Rose DG; Jarrell BE J Biomed Mater Res; 1994 Feb; 28(2):203-12. PubMed ID: 8207032 [TBL] [Abstract][Full Text] [Related]
30. Cellular origin and rate of endothelial cell coverage of PTFE grafts. Bull DA; Hunter GC; Holubec H; Aguirre ML; Rappaport WD; Putnam CW J Surg Res; 1995 Jan; 58(1):58-68. PubMed ID: 7830407 [TBL] [Abstract][Full Text] [Related]
31. A Novel Cardiovascular Prosthesis Made from Woven Ultrahigh-Molecular-Weight Polyethylene Fibers, Proof of Concept in a Sheep Model. Basir A; Loncq de Jong M; Vink A; Pasterkamp G; GrĂ¼ndeman P; Moll F; van Herwaarden J Ann Vasc Surg; 2018 Oct; 52():244-254.e1. PubMed ID: 29777850 [TBL] [Abstract][Full Text] [Related]
34. Clinical protocol. A phase IIb, randomized, multicenter, double-blind study of the efficacy and safety of Trinam (EG004) in stenosis prevention at the graft-vein anastomosis site in dialysis patients. Fuster V; Charlton P; Boyd A Hum Gene Ther; 2001 Nov; 12(16):2025-7. PubMed ID: 11727735 [TBL] [Abstract][Full Text] [Related]
35. Intimal integrity and fibrinolytic potential of reversed and in situ vein grafts. Boyd JH; Stevens R; Havey A; Silver D J Vasc Surg; 1987 Apr; 5(4):614-21. PubMed ID: 3560354 [TBL] [Abstract][Full Text] [Related]
37. Use of a Dacron shape-memory intravascular coil to achieve slow, progressive occlusion of the jugular vein in dogs. Nanfelt MR; Marolf AJ; Powers BE; Monnet E Vet Surg; 2011 Oct; 40(7):853-60. PubMed ID: 22380668 [TBL] [Abstract][Full Text] [Related]
39. Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production. Hattori K; Yamanouchi D; Banno H; Kobayashi M; Yamamoto K; Kajikuri J; Itoh T; Komori K J Vasc Surg; 2007 Jul; 46(1):116-23. PubMed ID: 17606127 [TBL] [Abstract][Full Text] [Related]
40. Biocompatibility and patency of a novel titanium vascular anastomotic device in a pig jugular vein. An S; Kim J; Lee D; Kim M; Byun K; Yun J; Jeong W; Son D Sci Rep; 2021 Sep; 11(1):17512. PubMed ID: 34471219 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]